Aptahem AB (publ) (NGM:APTA)
Sweden · Delayed Price · Currency is SEK 0.7120
0.00 (0.00%)
At close: Apr 7, 2026
Aptahem AB Market Cap
Aptahem AB has a market cap or net worth of 14.34 million as of April 9, 2026. Its market cap has increased by 91.25% in one year.
Market Cap
14.34M
Enterprise Value
11.38M
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.71
Market Cap Chart
Since April 17, 2015, Aptahem AB's market cap has decreased from 51.10M to 14.34M, a decrease of -71.93%. That is a compound annual growth rate of -10.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 14.93M | -37.82% |
| Dec 30, 2025 | 24.01M | 35.28% |
| Dec 30, 2024 | 17.75M | -4.71% |
| Dec 29, 2023 | 18.63M | -73.52% |
| Dec 30, 2022 | 70.35M | -20.14% |
| Dec 30, 2021 | 88.10M | -5.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 64.55M |
| Nanologica AB | 44.87M |
| Modus Therapeutics Holding AB | 36.61M |
| 2cureX AB | 27.61M |
| Guard Therapeutics International AB | 27.43M |
| ExpreS2ion Biotech Holding AB | 24.68M |
| Fluicell AB | 19.64M |
| Stayble Therapeutics AB | 12.23M |